{"version":"1.0","type":"link","title":"Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.","author_name":"Lynce F 외","author_url":"https://prs-insight.online/author/Lynce%20F","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/86850","thumbnail_width":1200,"thumbnail_height":630}